BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 34798839)

  • 1. Stepwise correlation of TP53 mutations from pancreaticobiliary maljunction to gallbladder carcinoma: a retrospective study.
    Kawakami S; Takano S; Fukasawa M; Shindo H; Takahashi E; Fukasawa Y; Hayakawa H; Kuratomi N; Kadokura M; Hosomura N; Amemiya H; Kawaida H; Kono H; Maekawa S; Ichikawa D; Enomoto N
    BMC Cancer; 2021 Nov; 21(1):1245. PubMed ID: 34798839
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of DNA double-strand breaks on pancreaticobiliary maljunction carcinogenesis.
    Kuraishi Y; Uehara T; Muraki T; Iwaya M; Kinugawa Y; Nakajima T; Watanabe T; Miyagawa Y; Umemura T
    Diagn Pathol; 2021 Aug; 16(1):72. PubMed ID: 34372868
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elevated bile amylase level without pancreaticobiliary maljunction is a risk factor for gallbladder carcinoma.
    Fujimoto T; Ohtsuka T; Nakashima Y; Gotoh Y; Date K; Mori Y; Sadakari Y; Takahata S; Oda Y; Nakamura M
    J Hepatobiliary Pancreat Sci; 2017 Feb; 24(2):103-108. PubMed ID: 28002646
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relation between K-ras codon 12 mutation and p53 protein overexpression in gallbladder cancer and biliary ductal epithelia in patients with pancreaticobiliary maljunction.
    Masuhara S; Kasuya K; Aoki T; Yoshimatsu A; Tsuchida A; Koyanagi Y
    J Hepatobiliary Pancreat Surg; 2000; 7(2):198-205. PubMed ID: 10982614
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High frequency of TP53 but not K-ras gene mutations in Bolivian patients with gallbladder cancer.
    Asai T; Loza E; Roig GV; Ajioka Y; Tsuchiya Y; Yamamoto M; Nakamura K
    Asian Pac J Cancer Prev; 2014; 15(13):5449-54. PubMed ID: 25041017
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TP53 abnormalities are frequent and early events in the sequential pathogenesis of gallbladder carcinoma.
    Moreno M; Pimentel F; Gazdar AF; Wistuba II; Miquel JF
    Ann Hepatol; 2005; 4(3):192-9. PubMed ID: 16177659
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genomic profiling of gallbladder carcinoma: Targetable mutations and pathways involved.
    Mishra S; Kumari S; Srivastava P; Pandey A; Shukla S; Husain N
    Pathol Res Pract; 2022 Apr; 232():153806. PubMed ID: 35231860
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IL-33 overexpression in gallbladder cancers associated with pancreatobiliary maljunction.
    Tomioka Y; Sung YN; Sawada R; Hong SM; Akita M; Itoh T; Ajiki T; Fukumoto T; Zen Y
    Histopathology; 2019 Sep; 75(3):365-375. PubMed ID: 30882917
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characteristic submucosal alteration in biliary carcinogenesis of pancreaticobiliary maljunction with a focus on inflammasome activation.
    Yamashita S; Takasu C; Morine Y; Ishibashi H; Ikemoto T; Mori H; Yamada S; Oya T; Tsuneyama K; Shimada M
    J Hepatobiliary Pancreat Sci; 2023 Apr; 30(4):462-472. PubMed ID: 36259178
    [TBL] [Abstract][Full Text] [Related]  

  • 10. p53 gene mutation and p53 protein overexpression in a patient with simultaneous double cancer of the gallbladder and bile duct associated with pancreaticobiliary maljunction.
    Kasuya K; Nagakawa Y; Matsudo T; Ozawa T; Tsuchida A; Aoki T; Itoi T; Itokawa F
    J Hepatobiliary Pancreat Surg; 2009; 16(3):376-81. PubMed ID: 19183832
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship between pancreaticobiliary maljunction and gallbladder carcinoma: meta-analysis.
    Deng YL; Cheng NS; Lin YX; Zhou RX; Yang C; Jin YW; Xiong XZ
    Hepatobiliary Pancreat Dis Int; 2011 Dec; 10(6):570-80. PubMed ID: 22146619
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pancreaticobiliary maljunction and carcinogenesis to biliary and pancreatic malignancy.
    Funabiki T; Matsubara T; Miyakawa S; Ishihara S
    Langenbecks Arch Surg; 2009 Jan; 394(1):159-69. PubMed ID: 18500533
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mucosal damage in pancreaticobiliary maljunction is stronger in the gallbladder than in the bile duct.
    Kamakura M; Uehara T; Muraki T; Iwaya M; Asaka S; Nakajima T; Iwaya Y; Nagaya T; Yoshizawa T; Shimizu A; Kuraishi Y; Ota H; Umemura T
    Pathol Res Pract; 2024 Jan; 253():155011. PubMed ID: 38103363
    [TBL] [Abstract][Full Text] [Related]  

  • 14. K-ras point mutations in cancerous and noncancerous biliary epithelium in patients with pancreaticobiliary maljunction.
    Matsubara T; Sakurai Y; Sasayama Y; Hori H; Ochiai M; Funabiki T; Matsumoto K; Hirono I
    Cancer; 1996 Apr; 77(8 Suppl):1752-7. PubMed ID: 8608574
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical and genetic analysis of noncancerous and cancerous biliary epithelium in patients with pancreaticobiliary maljunction.
    Nagai M; Watanabe M; Iwase T; Yamao K; Isaji S
    World J Surg; 2002 Jan; 26(1):91-8. PubMed ID: 11898040
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Importance of early diagnosis of pancreaticobiliary maljunction without biliary dilatation.
    Takuma K; Kamisawa T; Tabata T; Hara S; Kuruma S; Inaba Y; Kurata M; Honda G; Tsuruta K; Horiguchi S; Igarashi Y
    World J Gastroenterol; 2012 Jul; 18(26):3409-14. PubMed ID: 22807610
    [TBL] [Abstract][Full Text] [Related]  

  • 17. K-ras and p53 gene mutations in noncancerous biliary lesions of patients with pancreaticobiliary maljunction.
    Matsubara T; Sakurai Y; Zhi LZ; Miura H; Ochiai M; Funabiki T
    J Hepatobiliary Pancreat Surg; 2002; 9(3):312-21. PubMed ID: 12353142
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Telomerase activity and Bcl-2 expression in gallbladders of pancreaticobiliary maljunction patients: a preliminary study.
    Ichikawa Y; Kamiyama M; Sekido H; Ishikawa T; Miura Y; Kamiya N; Morita T; Shimada H
    J Hepatobiliary Pancreat Surg; 2004; 11(1):34-9. PubMed ID: 15754044
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intracholecystic papillary neoplasm arising in a patient with pancreaticobiliary maljunction: a case report.
    Iwasaki T; Otsuka Y; Miyata Y; Einama T; Tsujimoto H; Ueno H; Ogata S; Kishi Y
    World J Surg Oncol; 2020 Nov; 18(1):292. PubMed ID: 33168026
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epithelial cell proliferation and gene mutation in the mucosa of gallbladder with pancreaticobiliary malunion and cancer.
    Obara T; Tanno S; Fujii T; Izawa T; Mizukami Y; Yanagawa N; Ura H; Kohgo Y
    J Hepatobiliary Pancreat Surg; 1999; 6(3):229-36. PubMed ID: 10526057
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.